Levy Lewis 4
4 · Teladoc Health, Inc. · Filed Sep 2, 2020
Insider Transaction Report
Form 4
Levy Lewis
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-09-01$219.34/sh−2,670$585,638→ 8,766 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-09-01−1,275→ 22,714 totalExercise: $38.55Exp: 2028-03-01→ Common Stock (1,275 underlying) - Exercise/Conversion
Common Stock
2020-09-01$38.55/sh+1,275$49,151→ 11,436 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-09-01−1,395→ 14,858 totalExercise: $35.45Exp: 2027-07-14→ Common Stock (1,395 underlying) - Exercise/Conversion
Common Stock
2020-09-01$35.45/sh+1,395$49,453→ 10,161 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.
- [F2]The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- [F3]The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.